Genomics offers new treatment options for infants with range of soft tissue tumors
(Wellcome Trust Sanger Institute) The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators. Whole genome sequencing of tumours revealed mutations which are targetable by existing drugs used to treat lung cancer and melanoma. The results have implications for clinical practice and the diagnosis of rare cancers in infants, and could lead to new, targeted treatment options for these children. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 18, 2018 Category: Biology Source Type: news

Strategies to Avoid Sunburn
FRIDAY, June 15, 2018 -- If you could protect yourself from cancer, you'd do it, right? Yet most Americans still aren't taking the easiest step to prevent the most commonly diagnosed type -- skin cancer, which will affect one in five people at some... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 15, 2018 Category: General Medicine Source Type: news

No difference in malignancy rates seen between tocilizumab and TNFi in patients with RA
(European League Against Rheumatism) The results of a study presented at the Annual European Congress of Rheumatology (EULAR 2018) examined rates of malignancy in patients with rheumatoid arthritis (RA), excluding non-melanoma skin cancer (NMSC), and found no difference between those newly treated with tocilizumab (TCZ) versus TNF inhibitors (TNFi). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

Cut your risk for liver cancer by HALF by just increasing your vitamin D levels
(Natural News) Did you know that roughly 38.4 percent of people will be diagnosed with some type of cancer during their lifetime? If you’re “lucky,” yours might just be a harmless melanoma that your dermatologist can remove in their office. If you’re really unlucky, on the other hand, you could end up with one of... (Source: NaturalNews.com)
Source: NaturalNews.com - June 15, 2018 Category: Consumer Health News Source Type: news

NICE rejects adjuvant use of breast cancer drug
Draft guidance dubs Perjeta ‘not cost effective’ Related items fromOnMedica NICE fast-tracks approval of new skin cancer treatment New breast cancer drug ‘unaffordable’ for NHS One in 10 children in phase I cancer trials respond to drugs Cancer strategies failed to improve one-year survival Genetic risk model could guide prostate cancer screening (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 15, 2018 Category: UK Health Source Type: news

Nottingham beauty therapists taught to spot skin cancer signs
There are more than 2,400 deaths from melanoma every year, according to Cancer Research UK. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 14, 2018 Category: Consumer Health News Source Type: news

Public Health Grand Rounds: Prevention and Control of Skin Cancer
Originally presented on Tuesday, April 21, 2015. Encore presentation scheduled for Tuesday, June 19, 2018, at 1:00 PM ET. (Source: PHPartners.org)
Source: PHPartners.org - June 14, 2018 Category: International Medicine & Public Health Source Type: news

Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy
Phase 1/2 clinical trial in patients with advanced solid tumors that have progressed on anti-PD-1/PD-L1 therapy to evaluate APX005M in combination with cabiralizumab and Opdivo Study to enroll metastatic non-small cell lung cancer (NSCLC), metastatic me... Biopharmaceuticals, Oncology Apexigen, cabiralizumab, Opdivo, NSCLC, melanoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2018 Category: Pharmaceuticals Source Type: news

Health Tip: Protect Your Skin
-- Healthy skin habits can make you look younger and reduce your risk of skin cancer. While ointments, creams and eye serums can mask the effects of aging, nothing beats a good skin-care routine, the American Academy of Dermatology says. The academy... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 14, 2018 Category: General Medicine Source Type: news

Sun Defenses Up in Transplant Patients After Skin Cancer Study
Increased odds of using multiple sun protection measures among organ transplant recipients (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 13, 2018 Category: Cancer & Oncology Tags: Dermatology, Gastroenterology, Nephrology, Oncology, Surgery, Journal, Source Type: news

Older melanoma patients respond better to immunotherapy
Anti-PD1 immunotherapy more effectively treated older melanoma patients, according to researchers who see potential in better targeting it to younger patients. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 13, 2018 Category: Consumer Health News Source Type: news

Sun Defenses Up in Transplant Patients After Skin Cancer Study
WEDNESDAY, June 13, 2018 -- For organ transplant recipients, participation in a skin cancer research study is associated with increased use of multiple sun protection behaviors, according to a research letter published online June 6 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 13, 2018 Category: Pharmaceuticals Source Type: news

Skin Cancer Rate Increasing
Title: Skin Cancer Rate IncreasingCategory: Doctor's& Expert's views on SymptomsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 6/13/2018 2:55:09 PM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 13, 2018 Category: Cancer & Oncology Source Type: news

Older melanoma patients have better response to immune checkpoint blockade therapy
(The Wistar Institute) Patient age correlates with response to immunotherapy in melanoma and depleting regulatory T cells in young patients may have a therapeutic potential to enhance response in younger patients, according to research from The Wistar Institute. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 13, 2018 Category: International Medicine & Public Health Source Type: news

Older melanoma patients may respond to anti-PD1 immunotherapy better than younger patients
(American Association for Cancer Research) With each decade of life, the likelihood of progression of melanoma after treatment with anti-PD1 immunotherapy decreased by 13 percent. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 13, 2018 Category: International Medicine & Public Health Source Type: news

Uveal Melanoma: Better Survival With Liver-Directed Therapy Uveal Melanoma: Better Survival With Liver-Directed Therapy
Treatment for liver metastases in uveal cancer has changed over 50 years. At ASCO, one study charted the survival benefits seen with newer localized therapies; the other showed benefits of radioembolization.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

How 53-year-old became one of the first NHS patients saved by ‘miracle’ cancer treatment
Eighteen months on from successful treatment for an aggressive type of skin cancer, Tina Manning, 53, of  Luton, faced the words no patient wants to hear. The cancer was back. (Source: the Mail online | Health)
Source: the Mail online | Health - June 11, 2018 Category: Consumer Health News Source Type: news

Analysis Highlights Changes in 8th Edition AJCC Melanoma Staging System
“Now that effective adjuvant therapy has arrived in melanoma, accurate staging and patient selection to optimize a risk/benefit ratio is crucial,” emphasizes lead author Max Madu. (Source: CancerNetwork)
Source: CancerNetwork - June 11, 2018 Category: Cancer & Oncology Authors: Bryant Furlow Source Type: news

Skin cancer signs: Seek shade between these hours in the day to prevent symptoms
SKIN cancer signs are usually noticeable - you ’re likely to see an abnormal change to an area of your skin. The disease is one of the most common cancers in the world, so it’s important to recognise all the signs. Using a sunscreen with an SPF factor is one of the main forms of preventing the disease. It’s also recommended you seek shade between particular hours in the day. (Source: Daily Express - Health)
Source: Daily Express - Health - June 11, 2018 Category: Consumer Health News Source Type: news

Skin Cancer Examinations More Likely for Indoor Tanning Users
Indoor tanning bed users more likely to have done skin cancer self - exams, had professional exams (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 7, 2018 Category: Cancer & Oncology Tags: Dermatology, Oncology, Journal, Source Type: news

Skin Cancer Examinations More Likely for Indoor Tanning Users
THURSDAY, June 7, 2018 -- Engaging in ultraviolet (UV) indoor tanning is associated with increased use of skin cancer examinations, according to a research letter published online May 30 in JAMA Dermatology. Kasey L. Morris, Ph.D., from the National... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 7, 2018 Category: Pharmaceuticals Source Type: news

T-VEC Immunotherapy Shows Promising Early Activity in Melanoma
Bryant FurlowJun 7, 2018The genetically engineered oncolytic herpes simplex virus produced promising clinical responses in stage IIIB –IVM1a melanoma. (Source: CancerNetwork)
Source: CancerNetwork - June 7, 2018 Category: Cancer & Oncology Authors: A Source Type: news

Determining the Role of the Gut Microbiome in Melanoma Treated With Anti –PD-1 ICIs
Jennifer Wargo, MDJun 6, 2018Patients who responded to anti –PD-1 therapy and experienced prolonged progression-free survival had a much greater diversity of gut bacteria. (Source: CancerNetwork)
Source: CancerNetwork - June 6, 2018 Category: Cancer & Oncology Authors: A Source Type: news

Pembrolizumab Is Effective in Unresectable Melanoma, at 4-Year Follow-Up
Dave LevitanJun 6, 2018After 4 years of follow-up, pembrolizumab demonstrated durable antitumor activity and improved outcomes over ipilimumab in advanced melanoma. (Source: CancerNetwork)
Source: CancerNetwork - June 6, 2018 Category: Cancer & Oncology Authors: A Source Type: news

Different outdoor professions carry different risks for skin cancer
(Wiley) One of the main risk factors for non-melanoma skin cancer (NMSC), the most common cancer worldwide, is solar ultraviolet radiation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 6, 2018 Category: Cancer & Oncology Source Type: news

Middle-aged men and melanoma risk
By 65, Caucasian men are reportedly twice as likely as women to get melanoma. And not only are they more likely to develop melanoma, but also they often have a more aggressive form of the disease, according to a report from Blue Cross Blue Shield Association. "Melanoma is often believed to be 'just another skin [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 6, 2018 Category: Databases & Libraries Source Type: news

Nivolumab More Effective Than Ipilimumab in Resected High-Risk Melanoma
Dave LevitanJun 5, 2018Extended follow-up from the CheckMate 238 trial confirmed the superior efficacy of nivolumab vs ipilimumab in patients with stage III and IV resected melanoma. (Source: CancerNetwork)
Source: CancerNetwork - June 5, 2018 Category: Cancer & Oncology Authors: A Source Type: news

SkinNinja: This $4.5 Million App Spots Allergens And Cancer-Causing Ingredients In Your Skincare
" Quaternium-15 " is just one of many complicated names cosmetic companies give to the known cancer-causing ingredient formaldehyde. Luckily Jo Osborn, who has battled skin cancer herself, has built SkinNinja to tell you what's really hidden in your beauty regime, and she's just raised $1 million. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 5, 2018 Category: Pharmaceuticals Authors: Kitty Knowles, Forbes Staff Source Type: news

Woman left with scar after 'clogged pore' was actually cancer
Grandmother-of-two Joanne Wall, 48, from Barnsley, South Yorkshire, was stunned when a doctor told her a raised bump on her nose was skin cancer last March. She used to wear SPF 50. (Source: the Mail online | Health)
Source: the Mail online | Health - June 5, 2018 Category: Consumer Health News Source Type: news

Skin cancer symptoms: Do you have a large spot? - possible warning sign of the cancer
SKIN cancer symptoms include changes to your skin that are unusual. If you experience signs of the condition you should contact your GP. If you have spots that start to look a particular way, you may have the cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - June 5, 2018 Category: Consumer Health News Source Type: news

New treatment cures half of patients with untreatable skin cancer
A new study from the University of Texas has found a new treatment in the form of a drug that could cure half of all patients with an incurable form of skin cancer by attacking tumors. (Source: the Mail online | Health)
Source: the Mail online | Health - June 4, 2018 Category: Consumer Health News Source Type: news

Merck's Keytruda shows promise in treating advanced melanoma
(Reuters) - Merck& Co Inc said on Monday long-term data from its cancer immunotherapy Keytruda showed promise in treating advanced melanoma patients, a day after announcing positive lung cancer data from the same treatment. (Source: Reuters: Health)
Source: Reuters: Health - June 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Idera Pharmaceuticals presents clinical data from the ILLUMINATE-204 trial of the combination of tilsotolimod and ipilimumab for anti-PD-1 refractory metastatic melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
(Tonic Life Communications USA) Idera Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with rare cancers and rare diseases, announced results from the ongoing ILLUMINATE-204 trial investigating tilsotolimod, Idera's intratumorally-delivered Toll-like Receptor 9 agonist, in combination with ipilimumab (Yervoy ® ). Current data show an overall response rate of 38 percent following treatment with the combination of tilsotolimod and ipilimumab. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2018 Category: International Medicine & Public Health Source Type: news

Checkpoint inhibitor shrinks advanced squamous cell skin cancer
(University of Texas M. D. Anderson Cancer Center) Clinical trials show that an immune checkpoint inhibitor shrinks the tumors of nearly half of patients with an incurable, advanced form of a common skin cancer, an international team led by a researcher at The University of Texas MD Anderson Cancer Center reports in the New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

Drug a New Weapon Against Advanced Lung Tumors
The drug has also worked well against other cancers. When former President Jimmy Carter was diagnosed with melanoma that had spread to his brain several years ago, it was Keytruda that threw the cancer into remission by curtailing the action of a protein known as PD-L1. (Source: WebMD Health)
Source: WebMD Health - June 3, 2018 Category: Consumer Health News Source Type: news

Nektar And Bristol Hurtle Forward With Experimental Cancer Drug
Nektar Pharmaceuticals and Bristol-Myers Squibb said results for their experimental cancer drug, NKTR-214, pushing forward into late-stage trials testing the medicine against melanoma, renal cell carcinoma, and urothelial cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 2, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NASDAQ:NKTR NYSE:BMY Source Type: news

Here Are The States Where People May Want To Wear More Sunscreen
A just released Blue Cross Blue Shield Association (BCBSA) showed which states had the highest and the lowest skin cancer rates. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 2, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Skin cancer - how long can you spend in the sun this summer without getting melanoma?
SKIN cancer symptoms can develop by spending too much time in the sun, and your risk increases if you get sunburnt. How long can you spend in the sunshine during the hot weather, and how can you protect yourself from a melanoma? (Source: Daily Express - Health)
Source: Daily Express - Health - June 1, 2018 Category: Consumer Health News Source Type: news

Facial Morphing Program May Deter Young Adults From Tanning
FRIDAY, June 1, 2018 -- A facial morphing intervention may reduce skin cancer risk behaviors among young adults, according to a study published in the June issue of Body Image. Aaron J. Blashill, Ph.D., from San Diego State University, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2018 Category: Pharmaceuticals Source Type: news

Skin cancer warning - How long can you spend in the sun this summer?
SKIN cancer symptoms can develop by spending too much time in the sun, and your risk increases if you get sunburnt. How long can you spend in the sunshine during the hot weather, and how can you protect yourself from a melanoma? (Source: Daily Express - Health)
Source: Daily Express - Health - June 1, 2018 Category: Consumer Health News Source Type: news

Convolutional Neural Network Tops Clinicians for Melanoma ID
CNN receiver operating characteristic curve had higher specificity compared with dermatologists'(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 1, 2018 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pathology, Journal, Source Type: news

Convolutional Neural Network Tops Clinicians for Melanoma ID
FRIDAY, June 1, 2018 -- The diagnostic performance of a deep learning convolutional neural network (CNN) seems better than that of dermatologists, according to a study published online May 28 in the Annals of Oncology. Holger A. Haenssle, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2018 Category: Pharmaceuticals Source Type: news

Britons 'risking skin damage and cancer due to SPF ignorance'
Many consumers are unaware the SPF rating on suncreams does not measure all-round sun protection, scientists sayBritons are putting themselves at risk of sunburn, long-lasting skin damage and even cancer as a result of their ignorance about how to choose and use suncare protection, England ’s senior pharmacists have warned.Amid risingskin cancerrates in the UK, theRoyal Pharmaceutical Society has for the first time published an online guide on how to select and correctly use the right products to keep safe in the sun.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 1, 2018 Category: Science Authors: Rebecca Smithers Consumer affairs correspondent Tags: Health Society Science Cancer Skin cancer Skincare Source Type: news

Cleveland Clinic Cancer Center experts present data at 2018 ASCO Annual Meeting
(Cleveland Clinic) At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, researchers from Cleveland Clinic Cancer Center will present data from several new studies, including a prospective clinical trial examining non-small cell lung cancer cells' response to immunotherapy; research on germline testing for melanoma; and interim results from a study testing a vaccine for glioblastoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 1, 2018 Category: International Medicine & Public Health Source Type: news

Sidney Kimmel Cancer Center scientists to present at ASCO Annual Meeting
(Thomas Jefferson University) Scientists from the Sidney Kimmel Cancer Center (SKCC) at Jefferson Health will be presenting research and leading discussions on various topics, including metastatic uveal melanoma, genetic counseling in men, immunotherapy in early stage lung cancer and solid tumors, quality of life among patients receiving treatment for T cell lymphoma and updates on the Cancer Moonshot during the Biden Cancer Initiative Colloquium at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, being held June 1-5 in Chicago. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 1, 2018 Category: Cancer & Oncology Source Type: news

Teledermoscopy for skin cancer referral: justifiable cost?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - June 1, 2018 Category: Drugs & Pharmacology Source Type: news

New procedure allows quick recovery for melanoma patients
A doctor at the University of Alabama at Birmingham has developed a new procedure that helps melanoma patients recover in a shorter amount of time. Carlo Contreras, assistant professor in the Division of Surgical Oncology and associate scientist with the UAB Comprehensive Cancer Center, discovered a minimally invasive approach to removing lymph nodes that UAB says isn’t offered anywhere else in the state. The procedure involves six small l aparoscopic incisions, whereas the traditional operation… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 31, 2018 Category: Health Management Authors: Angel Coker Source Type: news

Despite risk of breast cancer, few men undergo genetic tests, study finds
Cancer is one of the leading causes of death among Americans. At least 10 percent of cancers are caused by inherited mutations in genes such as BRCA1 and BRCA2. Parents with the cancer gene mutation have a 50 percent chance of passing it on to a son or daughter. It ’s well-known that women with BRCA are at a very high risk for breast and ovarian cancer. Less known is the fact that men with these mutations also are at risk of breast cancer and other cancers.Astudy published in April in JAMA Oncology finds that few men are screened for these genetic mutations — and the researchers strongly suggest that they be sc...
Source: UCLA Newsroom: Health Sciences - May 31, 2018 Category: Universities & Medical Training Source Type: news

' Face-Aging' Photos Convince Tanners to Shun the Sun
THURSDAY, May 31, 2018 -- Where fear of skin cancer has little effect, vanity may succeed. In a new study, sun worshippers who were shown computer images of how their face would age after years of ultraviolet (UV) light exposure often decided to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 31, 2018 Category: General Medicine Source Type: news

FDA OKs First Artificial Iris for Aniridia, Other Iris Defects FDA OKs First Artificial Iris for Aniridia, Other Iris Defects
The CustomFlex Artificial Iris treats adults and children with congenital aniridia or iris defects due to other reasons or conditions, such as albinism, traumatic injury, or surgical removal due to melanoma.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 30, 2018 Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news